Huang, Hongjuan <br/><br/>
Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice.  [electronic resource] 

 -  International immunopharmacology  Mar 2020 
 - 106123 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2019.106123  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>9,10-Dimethyl-1,2-benzanthracene<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Carcinogens<br/>Cell Line<br/>Cytokines--genetics<br/>Female<br/>Flavonoids--pharmacology<br/>Mice, Inbred ICR<br/>RNA, Small Interfering--genetics<br/>Shc Signaling Adaptor Proteins--genetics<br/>Skin Neoplasms--chemically induced<br/>Tetradecanoylphorbol Acetate<br/>Transcription Factor RelA--immunology